Tonix Pharmaceuticals Holding Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$10.17 | -$7.43 | -$8.80 |
| Q2 2024 | 1 | -$3.78 | -$2.77 | -$3.27 |
| Q3 2024 | 1 | -$4.48 | -$3.28 | -$3.88 |
| Q4 2024 | 1 | -$7.41 | -$0.47 | -$3.95 |
| Q1 2025 | 1 | -$7.39 | -$5.41 | -$6.40 |
| Q2 2025 | 1 | -$7.76 | -$5.68 | -$6.72 |
| Q3 2025 | 1 | -$8.50 | -$6.22 | -$7.36 |
| Q4 2025 | 1 | -$8.50 | -$6.22 | -$7.36 |
Tonix Pharmaceuticals Holding Corp. Earnings Date And Information
Tonix Pharmaceuticals Holding Corp. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-2.03 by $1.8. The company had revenue of 2.82 M for the quarter and had revenue of 7.77 M for the year. Tonix Pharmaceuticals Holding Corp. has generated $-219 earnings per share over the last year ($-219.09 diluted earnings per share) and currently has a price-to-earnings ratio of -0.09. Tonix Pharmaceuticals Holding Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Tonix Pharmaceuticals Holding Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$2.03 | -$0.23 | 1.8 | $3.15 M | $2.82 M |
| 08/16/2024 | Q2 2024 | -$9.91 | -$19.28 | -9.37 | $3.50 M | $2.21 M |
| 05/13/2024 | Q1 2024 | -$16.61 | -$5.91 | 10.7 | $2.48 M | |
| 04/01/2024 | Q4 2023 | -$27.53 | $3.78 M | |||
| 11/09/2023 | Q3 2023 | -$47.60 | -$58.40 | -10.8 | $5.80 M | $3.99 M |
| 08/10/2023 | Q2 2023 | -$88.82 | -$85.71 | 3.11 | $0 | |
| 05/08/2023 | Q1 2023 | -$79.87 | -$102.85 | -22.98 | $33.90 M | |
| 03/13/2023 | Q4 2022 | -$125.80 | -$111.06 | 14.74 | $0 | |
| 11/07/2022 | Q3 2022 | -$143.77 | -$4.24 | 139.53 | $0 | |
| 08/08/2022 | Q2 2022 | -$291.53 | -$244.55 | 46.98 | $9.03 M | |
| 05/09/2022 | Q1 2022 | -$318.98 | -$321.28 | -2.3 | $0 | |
| 03/14/2022 | Q4 2021 | -$446.57 | -$419.18 | 27.39 | $0 | |
| 11/08/2021 | Q3 2021 | -$446.57 | -$319.96 | 126.61 | $0 | |
| 08/09/2021 | Q2 2021 | -$446.57 | -$449.35 | -2.78 | $0 | |
| 05/10/2021 | Q1 2021 | -$382.77 | -$455.62 | -72.85 | $0 | |
| 03/15/2021 | Q4 2020 | -$574.16 | -$664.75 | -90.59 | $2.91 M | |
| 11/09/2020 | Q3 2020 | -$701.75 | -$603.27 | 98.48 | $0 | |
| 08/10/2020 | Q2 2020 | -$1,339.71 | $0.00 | $0 | ||
| 05/12/2020 | Q1 2020 | -$3,125.99 | $0.00 | $0 | ||
| 03/24/2020 | Q4 2019 | -$9,505.56 | $0.00 | $-500 |
Tonix Pharmaceuticals Holding Corp. Earnings: Frequently Asked Questions
-
When is Tonix Pharmaceuticals Holding Corp.'s earnings date?
Tonix Pharmaceuticals Holding Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Tonix Pharmaceuticals Holding Corp. beat their earnings estimates last quarter?
In the previous quarter, Tonix Pharmaceuticals Holding Corp. (:TNXP) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.03 by $1.8.
-
How can I listen to Tonix Pharmaceuticals Holding Corp.'s earnings conference call?
The conference call for Tonix Pharmaceuticals Holding Corp.'s latest earnings report can be listened to online.
-
How can I read Tonix Pharmaceuticals Holding Corp.'s conference call transcript?
The conference call transcript for Tonix Pharmaceuticals Holding Corp.'s latest earnings report can be read online.
-
How much revenue does Tonix Pharmaceuticals Holding Corp. generate each year?
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a recorded annual revenue of $7.77 M.
-
How much profit does Tonix Pharmaceuticals Holding Corp. generate each year?
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a recorded net income of $7.77 M. Tonix Pharmaceuticals Holding Corp. has generated $-219.09 earnings per share over the last four quarters.
-
What is Tonix Pharmaceuticals Holding Corp.'s price-to-earnings ratio?
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a price-to-earnings ratio of -0.09 and price/earnings-to-growth ratio is -0.
